Results 71 to 80 of about 898,322 (221)

Assessment of fecal bacterial viability and diversity in fresh and frozen fecal microbiota transplant (FMT) product in horses

open access: yesBMC Veterinary Research
AbstractBackgroundCurrently, lack of standardization for fecal microbiota transplantation (FMT) in equine practice has resulted in highly variable techniques, and there is no data on the bacterial metabolic activity or viability of the administered product.
Alicia E. Long   +7 more
openaire   +3 more sources

Research Progress of Berberine in Kidney Disease: Targeting Mitochondria and Ferroptosis

open access: yesiNew Medicine, EarlyView.
This figure illustrates the model‐specific renoprotective mechanisms of berberine (BBR) across three major kidney diseases. From left to right, the diagram shows that BBR targets distinct core pathways depending on the pathological context: in diabetic nephropathy (DN), BBR activates AMPK to improve mitochondrial energy metabolism; in acute kidney ...
Liuqing Wang   +3 more
wiley   +1 more source

Does the Internet promote the unregulated use of fecal microbiota transplantation: a potential public health issue?

open access: yes, 2018
Jonathan Philip Segal,1 Faisal Abassi,2 Cynthia Kanagasundaram,3 Ailsa Hart1 1Department of Gastroenterology, St Mark’s Hospital, Harrow, UK, 2Lister Hospital, Stevenage, UK, 3Department of Gastroenterology, Addenbrooke’s Hospital, Cambridge,
Segal JP   +3 more
core  

Gut microbiota dysbiosis‐mediated gut NLRP3 inflammasome activation exacerbates corticospinal tract injury after intracerebral hemorrhage

open access: yesInterdisciplinary Medicine, EarlyView.
Schematic depicting a gut‐brain pathway that exacerbates CST injury after ICH. Gut Microbiota Dysbiosis‐Mediated Gut NLRP3 Inflammasome Activation Exacerbates Corticospinal Tract Injury After Intracerebral Hemorrhage. Abstract Intracerebral hemorrhage (ICH) causes severe neurological deficits largely attributable to corticospinal tract (CST) injury ...
Meiqin Zeng   +11 more
wiley   +1 more source

The role of fecal microbiota transplantation in selected neurodegenerative diseases and neurodevelopmental disorders

open access: yes
Fecal microbiota transplantation (FMT) is a medical procedure that allows to establish a stable and healthy intestinal microbiota in various diseases believed to be related to a gut dysbiosis.
Anna Sopel   +7 more
core   +1 more source

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation

open access: yes, 2020
International audienceFecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota.
Marvin Edeas   +7 more
core   +1 more source

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children

open access: yesPeerJ, 2018
Background Fecal Microbiota Transplantation (FMT) is an innovative means of treating recurrent Clostridium difficile infection (rCDI), through restoration of gut floral balance.
Fareed, Shaaz   +9 more
openaire   +5 more sources

Fecal microbiota transplantation and microbiota‐based therapeutics in pediatric clinical practice: Current status and emerging indications

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Fecal microbiota transplantation (FMT) is a safe and effective treatment for recurrent or refractory Clostridioides difficile infection (rCDI) in children and adults. This review outlines the evidence behind FMT for rCDI, considerations in special pediatric populations, and limitations in current practice due to FMT access for patients under ...
Nikhil Pai   +3 more
wiley   +1 more source

Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia [PDF]

open access: yes, 2016
Clostridium difficile is the most common cause of hospital-acquired diarrhea in Australia. In 2013, a randomized controlled trial demonstrated the effectiveness of fecal microbiota transplantation (FMT) for the treatment of recurrent Clostridium ...
Merlo, Gregory   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy